Get the Stockscreener App
4.97
1.39%
-0.07
After Hours:
5.06
0.09
+1.81%
Annexon Inc stock is traded at $4.97, with a volume of 5.45M.
It is down -1.39% in the last 24 hours and up +75.00% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$5.04
Open:
$5.03
24h Volume:
5.45M
Relative Volume:
2.15
Market Cap:
$740.81M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-2.8079
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
+7.81%
1M Performance:
+75.00%
6M Performance:
+83.39%
1Y Performance:
+10.20%
1-Day Range:
$4.95
$5.34
1-Week Range:
$4.71
$5.34
52-Week Range:
$1.285
$5.66
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650) 822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
4.97 | 751.24M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
What analysts say about Annexon Inc stockMarket Sentiment Surveys & Double Or Triple Profits - earlytimes.in
Annexon (NASDAQ:ANNX) Shares Up 6.2%Time to Buy? - MarketBeat
Independent Director of Annexon Jung Choi Buys More Stock - simplywall.st
Insider Buying: Annexon (NASDAQ:ANNX) Director Buys 4,115 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) Director Acquires $138,270.00 in Stock - MarketBeat
Insider Buying: William Carson Acquires Additional Shares of Ann - GuruFocus
Annexon (NASDAQ:ANNX) Stock Price Up 6.7%What's Next? - MarketBeat
Annexon, Inc. $ANNX Position Raised by Sio Capital Management LLC - MarketBeat
Clear Street Initiates Coverage on Annexon (ANNX) with a 'Buy' R - GuruFocus
Clear Street initiates coverage on Annexon stock with Buy rating By Investing.com - Investing.com Canada
Clear Street initiates coverage on Annexon stock with Buy rating - Investing.com
Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement - Finviz
Annexon FY2026 EPS Estimate Boosted by Cantor Fitzgerald - MarketBeat
12 Hot Penny Stocks to Invest in Right Now - Insider Monkey
Is Annexon Inc. stock oversold or undervaluedJuly 2025 Review & Risk Managed Trade Strategies - moha.gov.vn
Will Annexon Inc. stock benefit from AI adoption2025 Market Outlook & Real-Time Stock Price Movement Reports - moha.gov.vn
Will Annexon Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Target Return Focused Picks - BỘ NỘI VỤ
TPXimpact Holdings PLC Appoints New Nominated Adviser and Broker - The Globe and Mail
Annexon Biosciences Reports Increased R&D Expenses - MSN
Annexon explores GBS research with neurocritical care experts - Traders Union
Annexon Inc. (ANNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Annexon Insider Bought Shares Worth $3,600,784, According to a Recent SEC Filing - MarketScreener
Annexon launches $75M public offering of common stock - MSN
Annexon, Inc. (NASDAQ:ANNX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Insider Stock Purchases: November 22, 2025 - Quiver Quantitative
Satter Muneer buys Annexon (ANNX) shares worth $3.6 million By Investing.com - Investing.com Nigeria
[Form 4] Annexon, Inc. Insider Trading Activity - Stock Titan
Satter Muneer buys Annexon (ANNX) shares worth $3.6 million - Investing.com
Dir Satter Buys 822,613 ($3.6M) Of Annexon Inc [ANNX] - TradingView
Annexon, Inc. (ANNX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Can Annexon Inc. stock beat analyst upgradesJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Annexon (NASDAQ:ANNX) Shares Gap Up Following Insider Buying Activity - MarketBeat
How sentiment analysis helps forecast Annexon Inc.Weekly Profit Analysis & Community Verified Watchlist Alerts - newser.com
Annexon: Maintaining "Buy" Rating On Second C1q Inhibitor Advancement For Geographic Atrophy - Seeking Alpha
Wells Fargo Boosts Annexon’s Price Target Amid Optimism for Trial Success - StocksToTrade
Annexon Shares Rise After Director's $5.06 Million Stock Purchase - MarketScreener
Annexon stock rises after director purchases shares - MSN
Annexon stock rises after director purchases shares (ANNX:NASDAQ) - Seeking Alpha
Annexon Stock Surges on Positive Vonaprument Phase 3 Outlook - timothysykes.com
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed By Investing.com - Investing.com Australia
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed - Investing.com India
Annexon, Inc. Stock (ANNX) Opinions on Recent Public Offering and Insider Purchase - Quiver Quantitative
Why analysts upgrade Annexon Inc. stockQuarterly Portfolio Report & AI Enhanced Execution Alerts - newser.com
Annexon Insider Bought Shares Worth $5,055,000, According to a Recent SEC Filing - MarketScreener
Satter Muneer a buys Annexon (ANNX) shares worth $5m - Investing.com India
Satter Muneer a buys Annexon (ANNX) shares worth $5m By Investing.com - Investing.com Nigeria
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):